CTNNB1 and Alzheimer disease: Among the earliest lines of evidence supporting this association was the observation that PSEN1, involved in the proteolytic processing that produces amyloid-beta peptides, stabilizes beta-catenin and that AD-associated mutations reduce this stabilization [29].